Merck to buy experimental drug targeting B-cell diseases for up to $1.3 billion 0 09.08.2024 14:54 MarketWatch.com Abnormal B cells can cause a range of diseases, from autoimmune diseases to cancers. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
